Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-25 @ 5:03 AM
NCT ID:
NCT07088718
Eligibility Criteria:
FOLLOWING ELIGIBILITY CIRTERIA OF THE SURPASS-CVOT TRIAL
Inclusion Criteria:
* History of MI, surgical or percutaneous coronary/carotid peripheral artery revascularization
* BMI ≥25.0kg/m2
* Type 2 diabetes, diagnosis of coronary/carotid/peripheral artery disease
* Age ≥40 years
* Male or female sex
Exclusion Criteria:
* Medullary thyroid carcinoma, MEN syndrome type 2, malignancy
* Treatment for diabetic retinopathy//macular edema, pancreatitis, gastric emptying abnormality/bariatric surgery, liver disease, end-stage renal disease or dialysis, pregnancy
* Prior use of pramlintide or any GLP-1-RA except tirzepatide or dulaglutide
* Cardiovascular event, hospitalization for heart failure
* Concurrent use of both drugs i.e. tirzepatide and dulaglutide
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT07088718
Study Brief:
Protocol Section:
NCT07088718